Drug Interactions Database

6278 interactions from BNF 85 - Check your medicines

Source: BNF 85
enzalutamide verapamil

decreases exposure

Unknown Study
eplerenone lithium

increases concentration

Unknown Theoretical
eplerenonevery digoxin

increases exposure

Unknown Study
ergometrine noradrenaline

increases risk of peripheralvasoconstriction

Unknown Anecdotal
ergometrine noradrenalinenorepinephrine

increases risk of peripheralvasoconstriction

Unknown Anecdotal
ergometrine sympathomimetics,vasoconstrictor

increases risk of peripheralvasoconstriction

Unknown Anecdotal
erlotinib aspirin

increases risk of gastrointestinalperforation

Unknown Theoretical
erlotinib corticosteroids

increases risk of gastrointestinalperforation

Unknown Theoretical
erlotinib coumarins

increases anticoagulant effect

Unknown Anecdotal
erlotinib high-dose

increases risk of gastrointestinalperforation

Unknown Theoretical
erlotinib phenindione

increases risk of bleedingevents

Unknown Theoretical
erlotinib theactivecomponentofsacituzumabgovitecan

increases exposure

Unknown Theoretical
erythromycin abemaciclib

increases exposure

Unknown Study
erythromycin acalabrutinib

increases exposure

Unknown Study
erythromycin alphablockers

increases exposure

Unknown Theoretical
erythromycin alprazolam

increases exposure

Unknown Study
erythromycin antifungals,azoles

increases exposure

Unknown Theoretical
erythromycin antihistamines,non-sedating

increases exposure

Unknown Theoretical
erythromycin avapritinib

increases exposure

Unknown Study
erythromycin axitinib

increases exposure

Unknown Study
erythromycin bedaquiline

increases exposure

Unknown Theoretical
erythromycin benzodiazepines

increases exposure

Unknown Study
erythromycin brigatinib

increases exposure

Unknown Study
erythromycin bromocriptine

increases exposure

Unknown Theoretical
erythromycin cabazitaxel

increases exposure

Unknown Theoretical
erythromycin ceritinib

increases exposure

Unknown Study
erythromycin ciclosporin

increases exposure

Unknown Study
erythromycin cilostazol

increases exposure

Unknown Study
erythromycin cobimetinib

increases exposure

Unknown Study
erythromycin colchicine

increases exposure

Unknown Study
erythromycin dabrafenib

increases exposure

Unknown Study
erythromycin darifenacin

increases exposure

Unknown Study
erythromycin dasatinib

increases exposure

Unknown Study
erythromycin dienogest

increases exposure

Unknown Study
erythromycin diltiazem

increases exposure

Unknown Theoretical
erythromycin dipeptidylpeptidase-

increases exposure

Unknown Study
erythromycin docetaxel

increases exposure

Unknown Study
erythromycin dopaminereceptoragonists

increases exposure

Unknown Theoretical
erythromycin elexacaftor

increases exposure

Unknown Theoretical
erythromycin endothelinreceptorantagonists

increases exposure

Unknown Theoretical
erythromycin entrectinib

increases exposure

Unknown Theoretical
erythromycin eplerenone

increases exposure

Unknown Study
erythromycin ergometrine

increases risk of ergotism

Unknown Theoretical
erythromycin ergotamine

increases risk of ergotism

Unknown Theoretical
erythromycin erlotinib

increases exposure

Unknown Study
erythromycin fesoterodine

increases exposure

Unknown Study
erythromycin finerenone

increases exposure

Unknown Study
erythromycin gefitinib

increases exposure

Unknown Study
erythromycin guanfacine

increases concentration

Unknown Theoretical
erythromycin ibrutinib

increases exposure

Unknown Study
Important: This database uses data from the British National Formulary (BNF 85). It is for informational purposes only and is not a substitute for professional medical advice.